-
FY2025 EPS Estimate for CRISPR Therapeutics Cut by Analyst
Source: Buzz FX / 22 Feb 2025 03:11:13 America/New_York
FY2025 EPS Estimate for CRISPR Therapeutics Cut by Analyst Written by MarketBeat February 22, 2025 Share Link copied to clipboard. MaxCyte: Building the Future of Cell and Gene Therapy Innovation CRISPR Therapeutics AG ( NASDAQ:CRSP - Free
Read more...